Figure 3

Subgroup analysis for 5-year mortality according to cancer sites. RAAS renin–angiotensin–aldosterone system, HR hazard ratio.

Subgroup analysis for 5-year mortality according to cancer sites. RAAS renin–angiotensin–aldosterone system, HR hazard ratio.